
Formulation and rheology
Concentration, viscoelastic profile, extrusion force and stability designed around intended use and regulatory feasibility.

Technical qualification phase · Projects under review
Etternity is advancing the technical preparation and qualification of a platform for prefilled-syringe projects, including high-viscosity hyaluronic-acid and hydrogel formulations, with product, container and process engineered as one system.
01—04

Concentration, viscoelastic profile, extrusion force and stability designed around intended use and regulatory feasibility.

Assessment of barrel, plunger, closure and contact materials to protect function, integrity and administration experience.

Process definition for dose, bubbles, particles, closure and critical attributes in high-viscosity products.

Testing, controls, traceability and industrial-transfer strategy aligned with classification and agreed markets.
CDMO
An industrial capability for companies that need formulation, delivery system and manufacturing from one technical partner.
Platform currently in technical preparation and qualification for upcoming project phases. Project acceptance and manufacturing will depend on applicable commissioning, qualification and validation, regulatory classification, target market and written technical acceptance.
Industrial opportunity
We welcome early conversations with brands preparing requirements, risks and strategy ahead of platform availability.
Intended use, formulation, viscosity, dose, components, markets and forecast volume.
Critical product, container, process, performance and regulatory variables.
Prototypes, compatibility, stability, transfer and validation sequenced to the project.
Formula and component decisions made for repeatable manufacturing from the outset.
FAQ
The platform is currently in technical preparation and qualification for upcoming project phases. Manufacturing will only be offered after applicable qualification and validation are complete.
The focus includes hyaluronic acid, hydrogels and other high-viscosity formulations, subject to project-specific technical and regulatory review.
Yes. An early discussion can define requirements and a roadmap but does not imply manufacturing acceptance or an availability date.
Etternity Dermal
Share your prefilled-syringe requirements for inclusion in our capability assessment.